Inflammatory cytokines and features of the metabolic syndrome among patients treated with atypical antipsychotics

被引：0
|
作者：
Alméras, N [1 ]
Demers, MF [1 ]
Villeneuve, J [1 ]
Roy, MA [1 ]
Bouchard, RH [1 ]
Després, JP [1 ]
机构：
[1] Laval Hosp Res Ctr, Quebec City, PQ, Canada
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80367-5
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：350 / 351
页数：2
相关论文
共 50 条
  • [41] PREVALENCE OF THE METABOLIC SYNDROME AMONG SCHIZOPHRENIA PATIENTS ON ANTIPSYCHOTICS IN NIGERIA
    James, Bawo O.
    Lawani, Ambrose A.
    Okolo, Modupe
    Morakinyo, Olufemi
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 505 - 505
  • [42] Differential effects of atypical antipsychotics on indices of metabolic syndrome
    Meyer, J
    Newcomer, JW
    Loebel, AD
    Cohen, GM
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 566 - 566
  • [43] Differential effects of atypical antipsychotics on indices of metabolic syndrome
    Newcomer, JW
    Meyer, J
    Loebel, A
    Cohen, GM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S219 - S220
  • [44] Biological perspectives - Metabolic syndrome: Schizophrenia and atypical antipsychotics
    Keltner, Norman L.
    PERSPECTIVES IN PSYCHIATRIC CARE, 2006, 42 (03) : 204 - 207
  • [45] Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control
    Franch Pato, Clara M.
    Molina Rodriguez, Vicente
    Franch Valverde, Juan I.
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 38 - 44
  • [46] Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics
    Yang, Lin
    Chen, Jianhua
    Li, Yan
    Wang, Yan
    Liang, Shiqiao
    Shi, Yongyong
    Shi, Shenxun
    Xu, Yifeng
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (06): : 467 - 474
  • [47] Genetic Variants of Microsomal Triglyceride Transfer Protein (MTTP) Are Associated With Metabolic Syndrome in Schizophrenic Patients Treated With Atypical Antipsychotics
    Liou, Ying-Jay
    Tsai, Shih-Jen
    Wang, Ying-Chieh
    Bai, Ya Mei
    Hong, Chen-Jee
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (03) : 313 - 318
  • [48] Atherogenic metabolic risk profile observed among schizophrenic patients treated with atypical antipsychotics: Contribution of body fat distribution
    Blouin, M
    Roy, MA
    Bouchard, RH
    Despres, JP
    Almeras, N
    OBESITY RESEARCH, 2005, 13 : A183 - A183
  • [49] Metabolic syndrome in drug-naive first-episode psychosis treated with atypical antipsychotics
    Sahoo, Saddichha
    Ameen, Shahul
    Akhtar, Sayeed
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2007, 41 (07): : 629 - 629
  • [50] A comparison of adherence and persistence levels among schizophrenia patients treated with atypical antipsychotics
    Zhu, B
    Gibson, PJ
    Ascher-Svanum, H
    Opolka, J
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 349 - 349
12345